Updates on R/R MM: Is PFS Improved With KdD vs. Kd, IKd vs. Kd, Isa-Pd vs. Pd? Newly Approved Triple Class Refractory Drugs: Selinexor, Belantamab Mafodotin, Melflufen. CAR-T Cell Studies

March 16, 2021

0 Comments
Login to view comments. Click here to Login